4//SEC Filing
Hughes Steven George 4
Accession 0001599901-25-000166
CIK 0001599901other
Filed
Aug 21, 8:00 PM ET
Accepted
Aug 22, 5:20 PM ET
Size
9.2 KB
Accession
0001599901-25-000166
Insider Transaction Report
Form 4
Hughes Steven George
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2025-08-22$10.16/sh+2,208$22,433→ 41,075 total - Sale
Common Stock
2025-08-22$46.40/sh−2,208$102,462→ 38,867 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-08-22−2,208→ 72,875 totalExercise: $10.16Exp: 2034-01-19→ Common Stock (2,208 underlying)
Footnotes (3)
- [F1]The exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 12, 2024.
- [F2]This represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $44.64 to $47.03. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]This option was granted on January 20, 2024 and vests in equal installments of 2,208 shares on each monthly anniversary of such grant date, until it is fully vested and exercisable on January 20, 2028.
Documents
Issuer
Avidity Biosciences, Inc.
CIK 0001599901
Entity typeother
Related Parties
1- filerCIK 0001747528
Filing Metadata
- Form type
- 4
- Filed
- Aug 21, 8:00 PM ET
- Accepted
- Aug 22, 5:20 PM ET
- Size
- 9.2 KB